Expired listingThe listed claim deadline was 2026-10-16. This page remains available for reference; check the official settlement website for any later updates.

Eagle Pharmaceuticals Securities Settlement: Claim Deadline Passed

Investors who bought Eagle Pharmaceuticals common stock from August 9, 2022 through October 1, 2024 and suffered qualifying losses could claim under a $9.5 million settlement. Payments depend on recognized losses and approved claims after deductions; shares sold before May 9, 2023 have no recognized loss. The claim deadline was October 16, 2026.

Eagle Pharmaceuticals Securities Litigation

Claims closed Deadline: October 16, 2026

Who qualifies?

Investors who bought publicly traded Eagle Pharmaceuticals common stock from August 9, 2022, through October 1, 2024, and suffered qualifying losses. Shares sold before May 9, 2023, have no recognized loss under the allocation plan.

How much could I receive?

An estimated average of $1.18 per eligible share before fees and costs. Actual payments depend on your trading history and valid claims; calculated awards below $10 are not distributed.

Do I need supporting documents?

Yes. Claims require records of holdings, purchases and sales, such as broker confirmations or account statements. Representatives must also document their authority to file for someone else.

Do I need a notice ID or PIN?

The saved materials do not establish a notice ID or PIN requirement. Claimants must provide identifying information, the requested tax-ID digits and their investment records.

What is the deadline?

The deadline was October 16, 2026. Online claims had to be received, and mailed claims postmarked, by that date. It has passed.

How do I claim?

If you filed a claim, contact the administrator through the official settlement website for assistance. The stated claim deadline has passed.

Open the official settlement website →

What documents do I need to support my claim?

The notice requires documents for a payment claim. A signature, declaration, or notice alone is not enough. The Claim Form is the place to check the exact documentation requested for your transactions.

  • You must submit a Claim Form by the deadline and include adequate supporting documents.
  • Keep records showing your Eagle common-stock ownership and transactions. The notice does not list every acceptable document in its text; it says the Claim Form sets out the required supporting documentation.
  • A claim that is late or invalid will not receive a payment.

Why might a class-period purchase not result in a payment?

Buying stock during the class period does not by itself establish a payment amount. The Plan of Allocation uses transaction details and several limits to calculate each claim.

  • A recognized loss is calculated for each eligible purchase using the notice’s formula, including the purchase date, sale date or continued holding, purchase and sale prices, and the stated artificial-inflation amounts.
  • Shares bought during the class period generally must have been held through at least one listed corrective-disclosure date to have a recognized loss. A purchase sold before May 9, 2023 has a recognized loss of zero under the plan.
  • Your actual payment, if any, is a proportional share of the Net Settlement Fund compared with other approved claims. A calculated distribution below $10 will not be paid.

How are options and other nonstandard ways of acquiring shares treated?

The notice treats some ways of acquiring Eagle common stock differently. These rules can affect whether particular shares are included in a claim.

  • Option contracts themselves are not eligible for this settlement.
  • Common stock obtained by exercising a publicly traded option can be considered. For that stock, the exercise date is treated as the purchase or sale date, and the option’s strike price is treated as the stock price.
  • Common stock received through the exercise, conversion, or exchange of non-publicly traded Eagle securities is not eligible. Stock received in exchange for another company’s securities is also not eligible.

What if my Eagle shares were held in an ERISA retirement or benefit plan?

ERISA is a federal law that covers certain employee-benefit plans. The notice gives separate instructions for shares held through those plans.

  • Do not include Eagle common-stock transactions held through an ERISA-covered plan in your own Claim Form.
  • The notice says that claims for shares purchased by an ERISA plan may be made by the plan’s trustees.
  • You may include only Eagle shares that you personally bought or acquired outside the ERISA plan.

What is the difference between excluding myself and doing nothing?

Excluding yourself means leaving the settlement. It is different from simply not filing a claim.

  • If you remain in the Settlement Class and the settlement is approved, you will be bound by the Court’s orders and give up the released claims described in the notice against the defendants and related released parties.
  • If you validly exclude yourself, you cannot receive money from this settlement. Exclusion is the option that preserves the ability to pursue a separate lawsuit concerning the released claims.
  • Doing nothing does not preserve a payment claim: you remain in the class but will not be eligible for a payment without a valid Claim Form.

When could payments be sent, and could there be another distribution later?

The hearing date is not a payment date. The notice makes payment timing depend on later approval, appeal, and claim-processing steps.

  • The first distribution is made only after the Court has approved the settlement and allocation plan, the period for rehearing, appeals, or review has ended, and claims processing is complete.
  • The notice does not provide a calendar date for the first payments.
  • If money remains nine months after the initial distribution, the administrator may make another distribution when doing so is cost-effective. Only people who cashed their first checks and would receive at least $10 may receive a redistribution.

Other Important Dates

  • Exclusion deadline: 2026-07-29
  • Objection deadline: 2026-07-29
  • Final approval hearing: August 19, 2026, at 2:00 p.m.
  • Hearing location: Courtroom MLK 2C of the Martin Luther King Building & U.S. Courthouse, 50 Walnut Street, Newark, NJ 07101

Case Details

  • Total settlement fund: $9,500,000
  • Case name: Miller v. Eagle Pharmaceuticals, Inc.
  • Case number: 2:23-CV-23011-MAH
  • Court: United States District Court for the District of New Jersey
  • Administrator: Epiq
  • Official Settlement Website: https://www.EaglePharmaSecuritiesSettlement.com

Sources

Official Settlement Website
Claim form, FAQ, deadlines, administrator information
Visit Site →
Official Settlement Notice (PDF)
Court-approved notice describing eligibility and benefits
Open PDF →
Official NoticeRead the full notice

Official Notice

Read the notice PDF or the text version below.

Information last updated on 2026-10-21